top of page

Man Receives Pig's Heart

In January 2023, a significant medical milestone was achieved when David Bennett, a 57-year-old with terminal heart disease, received a heart transplant from a genetically modified pig. The surgery took place at the University of Maryland Medical Center and was authorized by the US FDA under emergency use guidelines.

The pig's heart used in the transplant had been genetically modified to remove genes that trigger rejection in humans and to include a gene that helps regulate blood sugar levels. The heart was also treated with a blood-thinning medication to prevent clot formation.

The operation was initially successful, and Mr. Bennett survived for two months following the transplant. However, his health began to decline in March, and he passed away on March 8. The exact cause of his death is still under investigation, but medical professionals do not believe it was due to rejection of the transplanted organ.

This groundbreaking achievement represents a significant advancement in xenotransplantation, the field of transplanting organs from one species to another. It suggests the potential use of pig organs to save the lives of individuals in need of organ transplants.

Using pig organs for transplantation has several advantages. Pigs are relatively easy to breed and raise, and their organs are similar in size and function to human organs. Furthermore, genetic modifications can be made to pigs to reduce the risk of organ rejection.

However, there are challenges to overcome before pig organs can be widely used for transplantation. Pigs can carry viruses that might be transmitted to humans, posing a risk. It is also essential to ensure that pig organs are compatible with the human immune system.

Despite these challenges, the successful pig-to-human heart transplant represents a promising step toward a future where pig organs could alleviate the organ transplant shortage and save many lives.


Xenotransplantation: The process of transplanting organs or tissues from one species (in this case, pigs) into another species (humans).

Genetically Modified: Changing the genes or DNA of an organism to make it better for a specific purpose. In this context, pigs were modified to have organs suitable for transplanting into humans.

Rejection: When the recipient's immune system recognizes the transplanted organ as foreign and tries to attack it.

Anticoagulant Drug: A medication that prevents the formation of blood clots, which can be dangerous in blood vessels.

Immune System: The body's defense system that protects against infections and foreign substances.

Blood Sugar Levels: The amount of sugar (glucose) in the blood. It's essential to regulate blood sugar to maintain health.

FDA (US Food and Drug Administration): A government agency that approves and monitors the safety of food, drugs, and medical treatments.

Virus: Tiny organisms that can cause diseases. In this context, it refers to diseases that pigs may carry and that could be passed to humans.

Compatibility: How well something (like a pig organ) works with or is accepted by another (the human body).

Organ Transplant: The surgical procedure of replacing a damaged or non-functioning organ with a healthy one from another person or animal.

Blood-Thinning Medication: A drug that reduces the risk of blood clot formation, which can lead to blockages in blood vessels.

Terminal Disease: A disease that is expected to be fatal, with no cure available.

Medical Milestone: A significant achievement or advancement in the field of medicine.

Emergency Use Authorization: A special permission granted by the FDA to use a medical treatment or procedure in urgent situations before it is fully approved.

Organ Shortage: A situation where there are not enough available organs for transplant to meet the demand of patients in need.


bottom of page